Ontario Latest Province to Cover Cost of Immuno-Oncology Treatment OPDIVO® (nivolumab)
Eligible Ontario residents with difficult-to-treat advanced cancers can now access an innovative new treatment option without having to pay out-of-pocket. MONTREAL, QUEBEC – March 22, 2017 – Bristol-Myers Squibb Canada...
Read More

